Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

462 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Gene promoter methylation signature predicts survival of head and neck squamous cell carcinoma patients.
Kostareli E, Hielscher T, Zucknick M, Baboci L, Wichmann G, Holzinger D, Mücke O, Pawlita M, Del Mistro A, Boscolo-Rizzo P, Da Mosto MC, Tirelli G, Plinkert P, Dietz A, Plass C, Weichenhan D, Hess J. Kostareli E, et al. Among authors: pawlita m. Epigenetics. 2016;11(1):61-73. doi: 10.1080/15592294.2015.1137414. Epub 2016 Jan 19. Epigenetics. 2016. PMID: 26786582 Free PMC article.
HPV-related methylation signature predicts survival in oropharyngeal squamous cell carcinomas.
Kostareli E, Holzinger D, Bogatyrova O, Hielscher T, Wichmann G, Keck M, Lahrmann B, Grabe N, Flechtenmacher C, Schmidt CR, Seiwert T, Dyckhoff G, Dietz A, Höfler D, Pawlita M, Benner A, Bosch FX, Plinkert P, Plass C, Weichenhan D, Hess J. Kostareli E, et al. Among authors: pawlita m. J Clin Invest. 2013 Jun;123(6):2488-501. doi: 10.1172/JCI67010. Epub 2013 May 1. J Clin Invest. 2013. PMID: 23635773 Free PMC article.
Sensitivity and specificity of antibodies against HPV16 E6 and other early proteins for the detection of HPV16-driven oropharyngeal squamous cell carcinoma.
Holzinger D, Wichmann G, Baboci L, Michel A, Höfler D, Wiesenfarth M, Schroeder L, Boscolo-Rizzo P, Herold-Mende C, Dyckhoff G, Boehm A, Del Mistro A, Bosch FX, Dietz A, Pawlita M, Waterboer T. Holzinger D, et al. Among authors: pawlita m. Int J Cancer. 2017 Jun 15;140(12):2748-2757. doi: 10.1002/ijc.30697. Epub 2017 Apr 4. Int J Cancer. 2017. PMID: 28316084 Free article.
Human papillomavirus as prognostic marker with rising prevalence in neck squamous cell carcinoma of unknown primary: A retrospective multicentre study.
Schroeder L, Boscolo-Rizzo P, Dal Cin E, Romeo S, Baboci L, Dyckhoff G, Hess J, Lucena-Porcel C, Byl A, Becker N, Alemany L, Castellsagué X, Quer M, León X, Wiesenfarth M, Pawlita M, Holzinger D. Schroeder L, et al. Among authors: pawlita m. Eur J Cancer. 2017 Mar;74:73-81. doi: 10.1016/j.ejca.2016.12.020. Epub 2017 Feb 10. Eur J Cancer. 2017. PMID: 28335889 Free article.
Low prevalence of HPV-driven head and neck squamous cell carcinoma in North-East Italy.
Baboci L, Holzinger D, Boscolo-Rizzo P, Tirelli G, Spinato R, Lupato V, Fuson R, Schmitt M, Michel A, Halec G, Da Mosto MC, Pawlita M, Del Mistro A. Baboci L, et al. Among authors: pawlita m. Papillomavirus Res. 2016 Dec;2:133-140. doi: 10.1016/j.pvr.2016.07.002. Epub 2016 Jul 16. Papillomavirus Res. 2016. PMID: 29074172 Free PMC article.
Antibodies against human papillomaviruses as diagnostic and prognostic biomarker in patients with neck squamous cell carcinoma from unknown primary tumor.
Schroeder L, Wichmann G, Willner M, Michel A, Wiesenfarth M, Flechtenmacher C, Gradistanac T, Pawlita M, Dietz A, Waterboer T, Holzinger D. Schroeder L, et al. Among authors: pawlita m. Int J Cancer. 2018 Apr 1;142(7):1361-1368. doi: 10.1002/ijc.31167. Epub 2017 Dec 4. Int J Cancer. 2018. PMID: 29159804 Free article.
Patterns of antibody responses to nonviral cancer antigens in head and neck squamous cell carcinoma patients differ by human papillomavirus status.
Gangkofner DS, Holzinger D, Schroeder L, Eichmüller SB, Zörnig I, Jäger D, Wichmann G, Dietz A, Broglie MA, Herold-Mende C, Dyckhoff G, Boscolo-Rizzo P, Ezic J, Marienfeld RB, Möller P, Völkel G, Kraus JM, Kestler HA, Brunner C, Schuler PJ, Wigand M, Theodoraki MN, Doescher J, Hoffmann TK, Pawlita M, Butt J, Waterboer T, Laban S. Gangkofner DS, et al. Among authors: pawlita m. Int J Cancer. 2019 Dec 15;145(12):3436-3444. doi: 10.1002/ijc.32623. Epub 2019 Aug 26. Int J Cancer. 2019. PMID: 31407331 Free article.
Absence of disruptive TP53 mutations in high-risk human papillomavirus-driven neck squamous cell carcinoma of unknown primary.
Boscolo-Rizzo P, Schroeder L, Sacchetto V, Holzinger D, Da Mosto MC, Tirelli G, Dal Cin E, Mantovani M, Menegaldo A, Del Mistro A, Romeo S, Dei Tos AP, Niero M, Rigo S, Dyckhoff G, Hess J, Alemany L, Quer M, León X, Polesel J, Pawlita M, Bertorelle R. Boscolo-Rizzo P, et al. Among authors: pawlita m. Head Neck. 2019 Nov;41(11):3833-3841. doi: 10.1002/hed.25915. Epub 2019 Aug 15. Head Neck. 2019. PMID: 31414564
Antibody Responses to Cancer Antigens Identify Patients with a Poor Prognosis among HPV-Positive and HPV-Negative Head and Neck Squamous Cell Carcinoma Patients.
Laban S, Gangkofner DS, Holzinger D, Schroeder L, Eichmüller SB, Zörnig I, Jäger D, Wichmann G, Dietz A, Broglie MA, Herold-Mende CC, Dyckhoff G, Boscolo-Rizzo P, Ezić J, Marienfeld R, Möller P, Kraus JM, Völkel G, Kestler HA, Brunner C, Schuler PJ, Wigand MC, Theodoraki MN, Doescher J, Hoffmann TK, Pawlita M, Waterboer T, Butt J. Laban S, et al. Among authors: pawlita m. Clin Cancer Res. 2019 Dec 15;25(24):7405-7412. doi: 10.1158/1078-0432.CCR-19-1490. Epub 2019 Aug 23. Clin Cancer Res. 2019. PMID: 31444248
462 results